You can buy or sell Gamida Cel and other stocks, options, and ETFs commission-free!
Gamida Cell Ltd. Ordinary Shares, also called Gamida Cel, is a clinical stage biopharmaceutical company engaging in the development of cell therapies to cure blood cancer and rare serious hematologic diseases. The company was founded by Tony Peled and Menashe Levy in 1998 and is headquartered in Jerusalem, Israel. The listed name for GMDA is Gamida Cell Ltd. Ordinary Shares.
52 Week High
52 Week Low
— per share
Expected Mar 9, Pre-Market